Readystate Asset Management’s Akero Therapeutics AKRO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$34.2M Buy
640,923
+540,423
+538% +$28.8M 1.05% 15
2025
Q1
$4.07M Buy
+100,500
New +$4.07M 0.14% 92